$280,000 of EDWARDS LIFESCIENCES LLC lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Ensuring Patient Access to Critical Breakthrough Products (H.R.5343/S.1717) (includes MCIT/TCET) Transitional Coverage for Emerging Technologies (TCET)/MCIT Policies promoting medical innovation Heart Valve Disease Awareness AI in Healthcare FDA Reauthorization/FDA User Fees Diversity in Clinical Trials Coverage with Evidence Development CMS Coverage Policies For Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.5343/S.1717) (includes MCIT/TCET) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Coverage with Evidence Development Tariffs"
You can find more data on corporate lobbying on Quiver Quantitative.
EW Insider Trading Activity
EW insiders have traded $EW stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $EW stock by insiders over the last 6 months:
- DONALD E JR BOBO (CVP,Strategy/Corp Development) has made 0 purchases and 7 sales selling 99,133 shares for an estimated $8,277,433.
- SCOTT B. ULLEM (CVP, Chief Financial Officer) has made 0 purchases and 4 sales selling 26,000 shares for an estimated $2,144,440.
- BERNARD J ZOVIGHIAN (CEO) has made 0 purchases and 3 sales selling 22,953 shares for an estimated $1,765,723.
- DANIEL J. LIPPIS (CVP, TAVR) has made 0 purchases and 8 sales selling 5,934 shares for an estimated $503,333.
- DAVEEN CHOPRA (CVP, TMTT & Surgical) sold 1,500 shares for an estimated $126,905
- ANDREW M. DAHL (SVP, Corporate Controller) sold 567 shares for an estimated $48,852
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
EW Hedge Fund Activity
We have seen 524 institutional investors add shares of EW stock to their portfolio, and 539 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 5,079,892 shares (+65.7%) to their portfolio in Q1 2026, for an estimated $406,797,751
- MILLENNIUM MANAGEMENT LLC removed 4,284,117 shares (-70.5%) from their portfolio in Q1 2026, for an estimated $343,072,089
- ARTISAN PARTNERS LIMITED PARTNERSHIP added 4,034,429 shares (+345.8%) to their portfolio in Q1 2026, for an estimated $323,077,074
- MARSHALL WACE, LLP removed 3,929,250 shares (-66.3%) from their portfolio in Q1 2026, for an estimated $314,654,340
- BANK OF AMERICA CORP /DE/ added 2,212,208 shares (+132.4%) to their portfolio in Q1 2026, for an estimated $177,153,616
- FMR LLC removed 2,078,777 shares (-12.5%) from their portfolio in Q1 2026, for an estimated $166,468,462
- NEUBERGER BERMAN GROUP LLC added 2,021,413 shares (+614.8%) to their portfolio in Q1 2026, for an estimated $161,874,753
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
EW Analyst Ratings
Wall Street analysts have issued reports on $EW in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 06/30/2026
To track analyst ratings and price targets for EW, check out Quiver Quantitative's $EW forecast page.
EW Price Targets
Multiple analysts have issued price targets for $EW recently. We have seen 13 analysts offer price targets for $EW in the last 6 months, with a median target of $100.0.
Here are some recent targets:
- Joanne Wuensch from Citigroup set a target price of $110.0 on 07/08/2026
- Vijay Kumar from Evercore ISI Group set a target price of $100.0 on 07/06/2026
- Marie Thibault from BTIG set a target price of $110.0 on 06/30/2026
- Shagun Singh from RBC Capital set a target price of $100.0 on 06/16/2026
- Joshua Jennings from TD Cowen set a target price of $104.0 on 06/02/2026
- Matt Miksic from Barclays set a target price of $110.0 on 04/27/2026
- William Plovanic from Canaccord Genuity set a target price of $85.0 on 04/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
